Corcept Therapeutics (CORT) Inventory (2012 - 2026)
Corcept Therapeutics recorded quarterly Inventory of $12.9 million in Q1 2026, little changed quarter-over-quarter from $12.9 million in Q4 2025, and down 10.29% year-over-year from $14.4 million in Q1 2025.
Corcept Therapeutics' Inventory history runs 15 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- In Q1 2026, Inventory fell 10.29% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (down 10.29% YoY), while the FY2025 annual figure was $12.9 million, up 3.67% from the prior year.
- Inventory came in at $12.9 million for Q1 2026 at Corcept Therapeutics, roughly flat from $12.9 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $14.4 million in Q1 2025 to a low of $5.1 million in Q1 2022.
- A 5-year average of $8.9 million and a median of $7.7 million in 2023 frame the typical range for Inventory.
- Across the five-year window, Inventory soared 99.83% in 2025 and declined 10.29% in 2026, its largest moves.
- Corcept Therapeutics' Inventory stood at $6.1 million in 2022, then increased by 26.72% to $7.7 million in 2023, then jumped by 60.57% to $12.4 million in 2024, then advanced by 3.67% to $12.9 million in 2025, then rose by 0.17% to $12.9 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $12.9 million, $12.9 million, and $12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | 12.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.89 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Sep 30, 2025 | 12.35 Mn |
| Jun 30, 2025 | 12.28 Mn |
| Mar 31, 2025 | 14.37 Mn |
| Dec 31, 2024 | 12.41 Mn |
| Sep 30, 2024 | 8.05 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 6.10 Mn |
| Sep 30, 2022 | 6.05 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 5.08 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 4.99 Mn |
| Jun 30, 2021 | 4.67 Mn |
| Mar 31, 2021 | 4.95 Mn |
| Dec 31, 2020 | 4.91 Mn |
| Sep 30, 2020 | 4.82 Mn |
| Jun 30, 2020 | 4.93 Mn |
| Mar 31, 2020 | 5.08 Mn |
| Dec 31, 2019 | 5.42 Mn |
| Sep 30, 2019 | 5.46 Mn |
| Jun 30, 2019 | 5.14 Mn |
| Mar 31, 2019 | 5.00 Mn |
| Dec 31, 2018 | 4.73 Mn |
| Sep 30, 2018 | 5.36 Mn |
| Jun 30, 2018 | 4.95 Mn |
| Mar 31, 2018 | 4.88 Mn |
| Dec 31, 2017 | 4.58 Mn |
| Sep 30, 2017 | 3.83 Mn |
| Jun 30, 2017 | 3.09 Mn |
| Mar 31, 2017 | 2.89 Mn |
| Dec 31, 2016 | 2.33 Mn |
| Sep 30, 2016 | 2.33 Mn |
| Jun 30, 2016 | 2.13 Mn |
| Mar 31, 2016 | 1.91 Mn |
| Dec 31, 2015 | 1.68 Mn |
| Sep 30, 2015 | 1.60 Mn |
| Jun 30, 2015 | 1.45 Mn |
| Mar 31, 2015 | 1.31 Mn |
| Dec 31, 2014 | 1.21 Mn |
| Sep 30, 2014 | 1.08 Mn |
| Jun 30, 2014 | 1.07 Mn |
| Mar 31, 2014 | 1.13 Mn |
| Dec 31, 2013 | 1.10 Mn |
| Sep 30, 2013 | 1.03 Mn |
| Jun 30, 2013 | 694,000.00 |
| Mar 31, 2013 | 1.03 Mn |
| Dec 31, 2012 | 853,000.00 |
| Sep 30, 2012 | 1.84 Mn |
| Jun 30, 2012 | 2.44 Mn |
| Mar 31, 2012 | 56,000.00 |